These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22332695)

  • 1. Proton pump inhibitors are associated with lower magnesium levels in older people with chronic kidney disease.
    Sumukadas D; McMurdo ME; Habicht D
    J Am Geriatr Soc; 2012 Feb; 60(2):392-3. PubMed ID: 22332695
    [No Abstract]   [Full Text] [Related]  

  • 2. [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
    Doornebal J; Bijlsma R; Brouwer RM
    Ned Tijdschr Geneeskd; 2009; 153():A711. PubMed ID: 19930736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis?
    Mikolasevic I; Milic S; Stimac D; Zaputovic L; Lukenda Zanko V; Gulin T; Jakopcic I; Klaric D; Gulin M; Orlic L
    Eur J Intern Med; 2016 May; 30():99-103. PubMed ID: 26905320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium in chronic kidney disease: challenges and opportunities.
    Kanbay M; Goldsmith D; Uyar ME; Turgut F; Covic A
    Blood Purif; 2010; 29(3):280-92. PubMed ID: 20090315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors and risk of hypomagnesemia.
    Pasina L; Zanotta D; Puricelli S; Djignefa DC; Bonoldi G
    Eur J Intern Med; 2015 Sep; 26(7):e25-6. PubMed ID: 26165831
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg.
    Furlanetto TW; Faulhaber GA
    Arch Intern Med; 2011 Aug; 171(15):1391-2. PubMed ID: 21555654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypomagnesemia induced by several proton-pump inhibitors.
    Broeren MA; Geerdink EA; Vader HL; van den Wall Bake AW
    Ann Intern Med; 2009 Nov; 151(10):755-6. PubMed ID: 19920278
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drugs affecting serum magnesium concentration].
    Kawamura Y
    Clin Calcium; 2012 Aug; 22(8):1211-6. PubMed ID: 22846357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor induced hypomagnesemia: a case report.
    Schor J; Ghabra O; Sekkarie M
    J Support Oncol; 2013 Jun; 11(2):103. PubMed ID: 23089234
    [No Abstract]   [Full Text] [Related]  

  • 10. Could proton pump inhibitors cause cancer?
    Rosch PJ
    Arch Intern Med; 2010 Oct; 170(19):1775-6. PubMed ID: 20975029
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of PPIs are not associated with mortality in institutionalized older people.
    Wilson N; Gnjidic D; March L; Sambrook P; Hilmer SN
    Arch Intern Med; 2011 May; 171(9):866; author reply 866-7. PubMed ID: 21555671
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent hypomagnesemia with proton-pump inhibitor rechallenge.
    Quasdorff M; Mertens J; Dinter J; Steffen HM
    Ann Intern Med; 2011 Sep; 155(6):405-7. PubMed ID: 21930865
    [No Abstract]   [Full Text] [Related]  

  • 13. Proton pump inhibitors and chronic kidney disease: is it time to sound the alarm?
    Wyatt CM
    Kidney Int; 2016 Apr; 89(4):732-3. PubMed ID: 26994567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In brief: PPI's and hypomagnesemia.
    Med Lett Drugs Ther; 2011 Apr; 53(1361):25. PubMed ID: 21464802
    [No Abstract]   [Full Text] [Related]  

  • 15. Proton pump inhibitors and hypomagnesemia in patients with arrhythmias.
    Ragupathi L; Fonseka N; Sendecki JA; McCarey MM; Breecker SW; Whellan DJ
    Int J Clin Pract; 2015 Dec; 69(12):1525-6. PubMed ID: 26647010
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypomagnesemia, chronic kidney disease and cardiovascular mortality: pronounced association but unproven causation.
    Dousdampanis P; Trigka K; Fourtounas C
    Hemodial Int; 2014 Oct; 18(4):730-9. PubMed ID: 24641780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of proton pump inhibitors and mortality among institutionalized older people.
    Bell JS; Strandberg TE; Teramura-Gronblad M; Laurila JV; Tilvis RS; Pitkälä KH
    Arch Intern Med; 2010 Sep; 170(17):1604-5. PubMed ID: 20876414
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
    Cundy T; Dissanayake A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):338-41. PubMed ID: 18221401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seizure and tetany secondary to hypomagnesaemic hypoparathyroidism induced by a proton-pump inhibitor.
    Pasina L; Zanotta D; Puricelli S; Bonoldi G
    Eur J Clin Pharmacol; 2017 Apr; 73(4):511-512. PubMed ID: 27896379
    [No Abstract]   [Full Text] [Related]  

  • 20. Proton pump inhibitors and severe hypomagnesaemia.
    Cundy T; Mackay J
    Curr Opin Gastroenterol; 2011 Mar; 27(2):180-5. PubMed ID: 20856115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.